Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000279616, referred to as "novel transcript, sense intronic to C6orf163", appears to be an uncharacterized or low-evidence transcript associated with the gene C6orf163 (Chromosome 6 Open Reading Frame 163). The transcript itself does not have a widely recognized function, classification, or therapeutic relevance in the current literature or major gene databases. Chromosome 6 Open Reading Frame 163 (C6orf163) is a protein-coding gene of uncertain biological function, with some tentative disease associations at the gene level, including pontocerebellar hypoplasia and congenital disorder of glycosylation. The specified target, ENSG00000279616 (novel transcript, sense intronic to C6orf163), is an intronic transcript and not recognized in reference as a canonical target, druggable protein, or receptor. There is no evidence for molecular classification, disease mechanism, drug interaction, or biomarker utility for this transcript at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, sense intronic to C6orf163.